Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 67, Issue 1, 2008, Pages 120-123

  Nihtyanova, S I ^a   Brough, G M ^a   Black, C M ^a   Denton, C P ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; IMMUNOSUPPRESSIVE AGENT; PROSTACYCLIN; SEROTONIN UPTAKE INHIBITOR; VASODILATOR AGENT;

ADULT; AMPUTATION; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL VASCULOPATHY; FEMALE; GANGRENE; HOSPITAL BASED CASE CONTROL STUDY; HOSPITALIZATION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYMPATHECTOMY; SYSTEMIC SCLEROSIS; ULCER; VASCULAR DISEASE;

ADULT; ARTERIAL OCCLUSIVE DISEASES; BACTERIAL INFECTIONS; FEMALE; FINGERS; GANGRENE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, DIFFUSE; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; SKIN ULCER;

EID: 37749022477     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.072686     Document Type: Article

References (8)

1. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139-53.
2. Mawdsley AH. Patient perception of UK scleroderma services - results of an anonymous questionnaire. Rheumatology 2006;45:1573.
3. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004;50:3985-93.
4. Gliddon AE, Dore CJ, Maddison PJ, Ouins Trial Study Group. Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis. Arthritis Rheum 2006;55:473-9.
5. Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2006;2:134-44.
6. Ostojic P, Damjanov N, Pavlov-Dolijanovic S, Radunovic G. Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease. Clin Hemorheol Microcirc 2004;31:281-5.
7. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
8. Herrick AL, Heaney M, Hollis S, Jayson MI. Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia. Ann Rheum Dis 1994;53:540-2.